Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.

Saved in:
Bibliographic Details
Title: Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
Authors: Chandran A; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Rosenheim J; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Nageswaran G; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Swadling L; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Pollara G; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Gupta RK; Institute for Global Health, University College London, London WC1E 6BT, UK., Burton AR; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Guerra-Assunção JA; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Woolston A; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Ronel T; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Pade C; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK., Gibbons JM; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK., Sanz-Magallon Duque De Estrada B; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Robert de Massy M; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Whelan M; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Semper A; National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JQ, UK., Brooks T; National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JQ, UK., Altmann DM; Department of Immunology and Inflammation, Imperial College London, London SW7 2BX, UK., Boyton RJ; Department of Infectious Disease, Imperial College London, London SW7 2BX, UK.; Lung Division, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., McKnight Á; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK., Captur G; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK.; MRC Unit for Lifelong Health and Ageing, University College London, London WC1E 6BT, UK., Manisty C; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK., Treibel TA; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK., Moon JC; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK., Tomlinson GS; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Maini MK; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Chain BM; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Noursadeghi M; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Corporate Authors: COVIDsortium Investigators
Source: Cell reports. Medicine [Cell Rep Med] 2022 Mar 04; Vol. 3 (3), pp. 100557. Date of Electronic Publication: 2022 Mar 04 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-3791
DOI:10.1016/j.xcrm.2022.100557